← Back to Search

Cognitive Behavioral Therapy for Smoking Cessation in HIV/AIDS

N/A
Recruiting
Led By Jasper Smits, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-79 years old
Be older than 18 years old
Must not have
Cognitive behavioral therapy for anxiety within the past year
Untreated or unstable psychiatric disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time frame: 6-month follow-up (approximately 6-months post quit date)
Awards & highlights

Summary

This trial is testing a cognitive-behavioral-based intervention to help smokers living with HIV quit smoking by reducing anxiety and depression.

Who is the study for?
This trial is for HIV-positive individuals aged 18-79 who smoke daily and are motivated to quit. They must understand English well enough to give informed consent. People using other tobacco products, undergoing current smoking cessation treatment, or with untreated/unstable psychiatric disorders can't participate.Check my eligibility
What is being tested?
The study tests a cognitive-behavioral-based intervention called QUIT against a Time-Matched Control (TM) to help smokers living with HIV quit by reducing anxiety and depression. It's a fully powered trial aiming to see if the intervention increases abstinence from smoking at 1-month and 6-month follow-ups.See study design
What are the potential side effects?
While specific side effects are not listed for this behavioral intervention, participants may experience discomfort discussing personal issues or stress related to quitting smoking during the sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 79 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have undergone cognitive behavioral therapy for anxiety in the last year.
Select...
I do not have untreated or unstable mental health issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame: 6-month follow-up (approximately 6-months post quit date)
This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: 6-month follow-up (approximately 6-months post quit date) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Long-Term Point Prevalence Smoking Abstinence
Short-Term Point Prevalence Smoking Abstinence

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: QUIT Treatment for Smoking Cessation and Distress ToleranceExperimental Treatment1 Intervention
Participants in this intervention arm will receive a Cognitive-Behavioral therapy-based intervention for smoking cessation in people living with HIV.
Group II: Time and Intensity-Match ControlActive Control1 Intervention
Participants in this control arm will receive an intervention matched in time and intensity with the experimental arm.
Group III: Standard of CareActive Control1 Intervention
At each clinic, routine assessment of smoking status occurs at least annually for patients receiving care, but prescription for pharmacotherapy for smoking cessation and referral for behavioral smoking cessation services are rare. Patients will receive the standard of care at the clinic they attend. SOC patients will also attend the first session that participants in the other sessions receive (pre-randomization), will come to the clinic for assessment only during the weeks lining up with sessions 6-10 for the other conditions, and receive the transdermal nicotine patch for 8 weeks.

Find a Location

Who is running the clinical trial?

Southern Methodist UniversityOTHER
35 Previous Clinical Trials
5,737 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,955 Previous Clinical Trials
13,212,318 Total Patients Enrolled
The Fenway InstituteOTHER
14 Previous Clinical Trials
2,452 Total Patients Enrolled

Media Library

QUIT Clinical Trial Eligibility Overview. Trial Name: NCT03904186 — N/A
Smoking/Cigarette Smoking Research Study Groups: Time and Intensity-Match Control, QUIT Treatment for Smoking Cessation and Distress Tolerance, Standard of Care
Smoking/Cigarette Smoking Clinical Trial 2023: QUIT Highlights & Side Effects. Trial Name: NCT03904186 — N/A
QUIT 2023 Treatment Timeline for Medical Study. Trial Name: NCT03904186 — N/A
Smoking/Cigarette Smoking Patient Testimony for trial: Trial Name: NCT03904186 — N/A
~64 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top